KR100572297B1 - 오메프라졸의 신규한 결정질 형태 - Google Patents

오메프라졸의 신규한 결정질 형태 Download PDF

Info

Publication number
KR100572297B1
KR100572297B1 KR1020017005830A KR20017005830A KR100572297B1 KR 100572297 B1 KR100572297 B1 KR 100572297B1 KR 1020017005830 A KR1020017005830 A KR 1020017005830A KR 20017005830 A KR20017005830 A KR 20017005830A KR 100572297 B1 KR100572297 B1 KR 100572297B1
Authority
KR
South Korea
Prior art keywords
omeprazole
omeprazole form
weight
composition
methoxy
Prior art date
Application number
KR1020017005830A
Other languages
English (en)
Korean (ko)
Other versions
KR20010107953A (ko
Inventor
카린 뢰브퀴비스트
데이비드 노르랜드
구넬 선덴
인그바르 이멘
Original Assignee
아스트라제네카 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베
Priority claimed from PCT/SE1998/002028 external-priority patent/WO1999008500A2/fr
Publication of KR20010107953A publication Critical patent/KR20010107953A/ko
Application granted granted Critical
Publication of KR100572297B1 publication Critical patent/KR100572297B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020017005830A 1998-11-10 1998-11-10 오메프라졸의 신규한 결정질 형태 KR100572297B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1998/002028 WO1999008500A2 (fr) 1998-11-10 1998-11-10 Nouvelle forme cristalline d'omeprazole

Publications (2)

Publication Number Publication Date
KR20010107953A KR20010107953A (ko) 2001-12-07
KR100572297B1 true KR100572297B1 (ko) 2006-04-24

Family

ID=43735642

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017005830A KR100572297B1 (ko) 1998-11-10 1998-11-10 오메프라졸의 신규한 결정질 형태

Country Status (5)

Country Link
KR (1) KR100572297B1 (fr)
AR (1) AR016700A1 (fr)
MY (1) MY118724A (fr)
SA (1) SA99190998B1 (fr)
TN (1) TNSN98221A1 (fr)

Also Published As

Publication number Publication date
SA99190998B1 (ar) 2006-03-25
AR016700A1 (es) 2001-07-25
KR20010107953A (ko) 2001-12-07
MY118724A (en) 2005-01-31
TNSN98221A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
US6384059B1 (en) Crystalline form of omeprazole
KR100624054B1 (ko) (ｓ)-오메프라졸의 칼륨염
KR100527804B1 (ko) Ｓ-오메프라졸의 칼륨염
SK285151B6 (sk) Neutrálna forma S-enantioméru omeprazolu, spôsob jeho prípravy, farmaceutická kompozícia s jeho obsahom a jeho použitie
US20120122933A1 (en) Compounds
US7345061B2 (en) Alkylammonium salts of omeprazole and esomeprazole
KR100572297B1 (ko) 오메프라졸의 신규한 결정질 형태
US7514560B2 (en) Crystalline form of omeprazole
MXPA01004651A (es) Nueva forma cristalina de omeprazol
CA2459012A1 (fr) Forme cristalline z du rabeprazole sodique et procede pour sa preparation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120322

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee